Prothena Corp Public (PRTA) EBIT Growth (5y) (2017 - 2026)
Prothena Corp Public (PRTA) EBIT Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.03% |
| Dec 31, 2025 | 4.40% |
| Sep 30, 2025 | -5.46% |
| Jun 30, 2025 | -25.92% |
| Mar 31, 2025 | -21.42% |
| Dec 31, 2024 | -22.76% |
| Sep 30, 2024 | -25.97% |
| Jun 30, 2024 | 38.82% |
| Mar 31, 2024 | -28.85% |
| Dec 31, 2023 | -28.11% |
| Sep 30, 2023 | 19.37% |
| Jun 30, 2023 | -1.07% |
| Mar 31, 2023 | -2.95% |
| Dec 31, 2022 | 72.68% |
| Sep 30, 2022 | 1.23% |
| Jun 30, 2022 | -18.97% |
| Mar 31, 2022 | -0.91% |
| Dec 31, 2021 | 7.65% |
| Sep 30, 2021 | 35.45% |
| Jun 30, 2021 | 21.94% |